Home » Authors » CenterWatch Staff

Articles by CenterWatch Staff

Baxter acquires AesRx

July 10, 2014

CenterWatch Staff

EMA’s clinical trial data policy delayed until October

July 10, 2014

CenterWatch Staff

CardioCell begins phase IIa trial using itMSC therapy for chronic heart failure

July 10, 2014

CenterWatch Staff

Portola, Daiichi Sankyo to collaborate on andexanet alfa study

July 9, 2014

CenterWatch Staff

AstraZeneca, Max Planck Institute to create satellite chemistry unit

July 9, 2014

CenterWatch Staff

Report: cancer immunotherapy market to hit $9B globally by 2022

July 9, 2014

CenterWatch Staff

Mariel Therapeutics to acquire Stryker's organ fibrosis assets

July 9, 2014

CenterWatch Staff

EFPIA launches IMI2—a $4.5B public-private healthcare partnership

July 9, 2014

CenterWatch Staff

AbbVie outlines revised $51.3B Shire offer

July 9, 2014

CenterWatch Staff

Prescriptions in England up 60%, but costs up only 15% since 2003

July 9, 2014

CenterWatch Staff

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here

Articles by CenterWatch Staff

Baxter acquires AesRx

EMA’s clinical trial data policy delayed until October

CardioCell begins phase IIa trial using itMSC therapy for chronic heart failure

Portola, Daiichi Sankyo to collaborate on andexanet alfa study

AstraZeneca, Max Planck Institute to create satellite chemistry unit

Report: cancer immunotherapy market to hit $9B globally by 2022

Mariel Therapeutics to acquire Stryker's organ fibrosis assets

EFPIA launches IMI2—a $4.5B public-private healthcare partnership

AbbVie outlines revised $51.3B Shire offer

Prescriptions in England up 60%, but costs up only 15% since 2003

Featured Products

Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Best Practices for Clinical Trial Site Management

Featured Stories

Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

Ask the Experts: Applying Quality by Design to Protocols

Clinical Trials Need Greater Representation of Obese Patients, Experts Say

FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.